缺血性卒中或TIA后戒烟与结局改善相关
本研究为前瞻性观察性队列研究,纳入IRIS试验中3876例非糖尿病卒中或TIA患者,随访中位4.8年。结果显示,与继续吸烟者相比,戒烟者5年卒中、心肌梗死或死亡风险显著降低(15.7% vs 22.6%,校正HR 0.66,95%CI 0.48-0.90)。
要点
- 缺血性卒中或TIA后戒烟与5年卒中、心肌梗死或死亡风险降低相关。
- 戒烟者5年绝对风险为15.7%,继续吸烟者为22.6%。
- 校正后HR为0.66(95%CI 0.48-0.90),提示显著获益。
核心结论
- 缺血性卒中或TIA后戒烟与4.8年随访期内显著健康获益相关。
研究设计与样本
- 前瞻性观察性队列研究,纳入IRIS试验中3876例非糖尿病卒中或TIA患者,随机接受吡格列酮或安慰剂,随访中位4.8年。
主要发现
- 基线时1072例(28%)为当前吸烟者,随机化时450例(42%)已戒烟。
- 戒烟者5年卒中、心肌梗死或死亡风险为15.7%,继续吸烟者为22.6%。
- 校正后风险比(HR)为0.66,95%置信区间(CI)0.48-0.90。
关键数值与推荐
- 主要结局为复发性卒中、心肌梗死或死亡,非IRIS方案预设。
- Cox回归模型校正IRIS试验预设变量:年龄、性别、指数事件(卒中vs TIA)、卒中史、高血压史、冠心病史、收缩压和舒张压。
临床怎么用
- 对缺血性卒中或TIA后仍吸烟的患者,应强调戒烟以改善长期预后。
局限性
- 主要结局非预设,为观察性分析,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether smoking cessation after an ischemic stroke or TIA improves outcomes compared to continued smoking. METHODS: We conducted a prospective observational cohort study of 3,876 nondiabetic men and women enrolled in the Insulin Resistance Intervention After Stroke (IRIS) trial who were randomized to pioglitazone or placebo within 180 days of a qualifying stroke or TIA and followed up for a median of 4.8 years. A tobacco use history was obtained at baseline and updated during annual interviews. The primary outcome, which was not prespecified in the IRIS protocol, was recurrent stroke, myocardial infarction (MI), or death. Cox regression models were used to assess the differences in stroke, MI, and death after 4.8 years, with correction for adjustment variables prespecified in the IRIS trial: age, sex, stroke (vs TIA) as index event, history of stroke, history of hypertension, history of coronary artery disease, and systolic and diastolic blood pressures. RESULTS: At the time of their index event, 1,072 (28%) patients were current smokers. By the time of randomization, 450 (42%) patients had quit smoking. Among quitters, the 5-year risk of stroke, MI, or death was 15.7% compared to 22.6% for patients who continued to smoke (adjusted hazard ratio 0.66, 95% confidence interval 0.48-0.90). CONCLUSION: Cessation of cigarette smoking after an ischemic stroke or TIA was associated with significant health benefits over 4.8 years in the IRIS trial cohort.
引用
- Epstein KA, Viscoli CM, Spence JD, et al. Smoking cessation and outcome after ischemic stroke or TIA. Neurology. 2017. PMID: 28887378. doi:10.1212/WNL.0000000000004524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。